Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SPNS Stock Forecast 2026-2027
$43.45
Current Price
$2.43B
Market Cap
Buy 0
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to SPNS Price Targets
+0.1%
To High Target of $43.50
+0.1%
To Median Target of $43.50
+0.1%
To Low Target of $43.50
SPNS Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
+64.8%
1 Year Change
0.0%
Year-to-Date Change
-0.2%
From 52W High of $43.52
+83.4%
From 52W Low of $23.69
📊 TOP ANALYST CALLS
Did SPNS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Sapiens is one of their latest high-conviction picks.
Latest SPNS Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, SPNS has a neutral consensus with a median price target of $43.50 (ranging from $43.50 to $43.50). The overall analyst rating is Buy (6.0/10). Currently trading at $43.45, the median forecast implies a 0.1% upside. This outlook is supported by 0 Buy, 2 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SPNS Analyst Ratings
0
Buy
2
Hold
0
Sell
SPNS Price Target Range
Low
$43.50
Average
$43.50
High
$43.50
Current: $43.45
Latest SPNS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SPNS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 13, 2025 | Needham | Mayank Tandon | Hold | Downgrade | $35.00 |
| May 9, 2025 | Barclays | Tavy Rosner | Underweight | Maintains | $31.00 |
| Feb 19, 2025 | Needham | Mayank Tandon | Buy | Reiterates | $35.00 |
| Feb 19, 2025 | Barclays | Tavy Rosner | Underweight | Maintains | $28.00 |
| Feb 3, 2025 | Jefferies | Surinder Thind | Hold | Downgrade | $28.00 |
| Nov 12, 2024 | Barclays | Tavy Rosner | Underweight | Maintains | $30.00 |
| Nov 12, 2024 | Needham | Mayank Tandon | Buy | Maintains | $35.00 |
| Aug 2, 2024 | Goldman Sachs | Kevin Kumar | Buy | Maintains | $43.00 |
| Aug 2, 2024 | Needham | Mayank Tandon | Buy | Maintains | $44.00 |
| Aug 2, 2024 | Barclays | Tavy Rosner | Underweight | Maintains | $38.00 |
| May 8, 2024 | Needham | Mayank Tandon | Buy | Reiterates | $38.00 |
| Feb 21, 2024 | Goldman Sachs | Kevin Kumar | Buy | Maintains | $38.00 |
| Feb 21, 2024 | Barclays | Tavy Rosner | Underweight | Maintains | $30.00 |
| Aug 3, 2023 | Goldman Sachs | Kevin Kumar | Buy | Maintains | $34.00 |
| Aug 3, 2023 | Barclays | Tavy Rosner | Underweight | Maintains | $28.00 |
| Aug 2, 2023 | Needham | Mayank Tandon | Buy | Maintains | $35.00 |
| May 5, 2023 | Barclays | Tavy Rosner | Underweight | Downgrade | $24.00 |
| Feb 22, 2023 | Barclays | Tavy Rosner | Equal-Weight | Maintains | $24.00 |
| Feb 22, 2023 | Needham | Mayank Tandon | Buy | Maintains | $24.00 |
| Feb 22, 2023 | Goldman Sachs | Kevin Kumar | Buy | Maintains | $26.00 |
Sapiens International Corporation N.V. (SPNS) Competitors
The following stocks are similar to Sapiens based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Sapiens International Corporation N.V. (SPNS) Financial Data
Sapiens International Corporation N.V. has a market capitalization of $2.43B with a P/E ratio of 37.8x. The company generates $564.33M in trailing twelve-month revenue with a 11.4% profit margin.
Revenue growth is +11.2% quarter-over-quarter, while maintaining an operating margin of +11.7% and return on equity of +13.0%.
Valuation Metrics
Market Cap
$2.43B
Enterprise Value
$2.41B
P/E Ratio
37.8x
PEG Ratio
-1.8x
Price/Sales
4.3x
Growth & Margins
Revenue Growth (YoY)
+11.2%
Gross Margin
+44.2%
Operating Margin
+11.7%
Net Margin
+11.4%
EPS Growth
-22.0%
Financial Health
Cash/Price Ratio
+3.4%
Current Ratio
1.5x
Debt/Equity
8.3x
ROE
+13.0%
ROA
+6.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Sapiens International Corporation N.V. (SPNS) Business Model
About Sapiens International Corporation N.V.
What They Do
Provider of software solutions for the insurance industry.
Business Model
The company generates revenue by offering a suite of software solutions tailored to the insurance sector, including life, pension, property, casualty, and reinsurance. Sapiens makes money through licensing its software, providing implementation services, and offering ongoing support and maintenance to clients, thereby ensuring long-term partnerships and recurring revenue streams.
Additional Information
Sapiens International Corporation is headquartered in Holon, Israel, and serves a global clientele across North America, Europe, and Asia. The company focuses on digital transformation for insurers by leveraging advanced technologies like cloud computing, artificial intelligence, and data analytics, positioning itself as a leader in the technology and insurance convergence.
Company Information
Sector
Technology
Industry
Software - Application
Employees
4,850
CEO
Mr. Roni Al-Dor
Country
Israel
IPO Year
1998
Website
www.sapiens.comSapiens International Corporation N.V. (SPNS) Latest News & Analysis
Latest News
Sapiens Reports Third Quarter 2025 Financial Results
5 months ago
Quick Summary
Sapiens International Corporation (NASDAQ: SPNS) reported its third-quarter financial results for 2025, ending September 30. Further details on performance were not provided in the excerpt.
Why It Matters
Sapiens International's Q3 financial results could impact stock performance, reflecting its growth and market position in the insurance software sector, influencing investor sentiment and decisions.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Sapiens (SPNS) reported Q3 earnings of $0.36 per share, surpassing estimates of $0.33. This is a slight decrease from $0.37 per share in the same quarter last year.
Why It Matters
Sapiens' earnings beat estimates, indicating strong performance and potential growth, but a decline from last year's earnings may raise concerns about future profitability.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Sapiens International Corporation (SPNS) will report its Q3 2025 financial results on November 13, 2025.
Why It Matters
Sapiens International's upcoming Q3 2025 financial results could impact stock performance and investor sentiment, offering insights into the company's growth and market position.
Source: PRNewsWire
Market Sentiment:
Neutral
Sapiens Launches Decision Analytics, Bringing Real-Time Visibility and Optimization to AI Decisioning
5 months ago
Quick Summary
Sapiens International Corporation launched Decision Analytics, enhancing its Sapiens Decision Platform with tools for enterprises to monitor and optimize automated decisions.
Why It Matters
The launch of Decision Analytics enhances Sapiens' competitive edge by improving automated decision-making transparency, potentially driving growth and increasing investor confidence in its SaaS offerings.
Source: PRNewsWire
Market Sentiment:
Neutral
Sapiens Customer Summit Highlighted Transformative Insurance Technology in Phoenix, Arizona
5 months ago
Quick Summary
Sapiens International Corporation hosted its annual North America Customer Summit in Phoenix from October 27-29, 2025, with around 540 participants from 130 insurance and partner companies.
Why It Matters
The participation of 540 industry professionals at Sapiens' summit highlights strong engagement and potential for growth in its software solutions for the insurance sector, signaling positive business momentum.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Sapiens International Corporation has partnered with Linqura to enhance P&C insurers' ability to scale their business insurance portfolios across various market conditions.
Why It Matters
The partnership enhances Sapiens' offerings, potentially increasing market share and revenue in the insurance sector, which may positively impact stock performance and investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SPNS Stock
What is Sapiens International Corporation N.V.'s (SPNS) stock forecast for 2026?
Based on our analysis of 8 Wall Street analysts, Sapiens International Corporation N.V. (SPNS) has a median price target of $43.50. The highest price target is $43.50 and the lowest is $43.50.
Is SPNS stock a good investment in 2026?
According to current analyst ratings, SPNS has 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $43.45. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SPNS stock?
Wall Street analysts predict SPNS stock could reach $43.50 in the next 12 months. This represents a 0.1% increase from the current price of $43.45. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Sapiens International Corporation N.V.'s business model?
The company generates revenue by offering a suite of software solutions tailored to the insurance sector, including life, pension, property, casualty, and reinsurance. Sapiens makes money through licensing its software, providing implementation services, and offering ongoing support and maintenance to clients, thereby ensuring long-term partnerships and recurring revenue streams.
What is the highest forecasted price for SPNS Sapiens International Corporation N.V.?
The highest price target for SPNS is $43.50 from at , which represents a 0.1% increase from the current price of $43.45.
What is the lowest forecasted price for SPNS Sapiens International Corporation N.V.?
The lowest price target for SPNS is $43.50 from at , which represents a 0.1% increase from the current price of $43.45.
What is the overall SPNS consensus from analysts for Sapiens International Corporation N.V.?
The overall analyst consensus for SPNS is neutral. Out of 8 Wall Street analysts, 0 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $43.50.
How accurate are SPNS stock price projections?
Stock price projections, including those for Sapiens International Corporation N.V., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 2:21 PM UTC